Naloxegol Market, Global Outlook and Forecast 2022-2028

August 2022 | 61 pages | ID: NB162988D54AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Naloxegol in Global, including the following market information:

Global Naloxegol Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Naloxegol market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Naloxegol include MOVANTIK, AstraZeneca, Aurobindo, MSN Life Sciences, Lepu, Daiichi Sankyo Company, Knight Therapeutics, Kyowa Kirin International and Nektar Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Naloxegol companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Naloxegol Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Naloxegol Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Capsule

Global Naloxegol Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Naloxegol Market Segment Percentages, by Application, 2021 (%)

• Pharmacy
• Hospital
• Clinic
• Others

Global Naloxegol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Naloxegol Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Naloxegol revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Naloxegol revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• MOVANTIK
• AstraZeneca
• Aurobindo
• MSN Life Sciences
• Lepu
• Daiichi Sankyo Company
• Knight Therapeutics
• Kyowa Kirin International
• Nektar Therapeutics
• RedHill Biopharma Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Naloxegol Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Naloxegol Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NALOXEGOL OVERALL MARKET SIZE

2.1 Global Naloxegol Market Size: 2021 VS 2028
2.2 Global Naloxegol Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Naloxegol Players in Global Market
3.2 Top Global Naloxegol Companies Ranked by Revenue
3.3 Global Naloxegol Revenue by Companies
3.4 Top 3 and Top 5 Naloxegol Companies in Global Market, by Revenue in 2021
3.5 Global Companies Naloxegol Product Type
3.6 Tier 1, Tier 2 and Tier 3 Naloxegol Players in Global Market
  3.6.1 List of Global Tier 1 Naloxegol Companies
  3.6.2 List of Global Tier 2 and Tier 3 Naloxegol Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Naloxegol Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Capsule
4.2 By Type - Global Naloxegol Revenue & Forecasts
  4.2.1 By Type - Global Naloxegol Revenue, 2017-2022
  4.2.2 By Type - Global Naloxegol Revenue, 2023-2028
  4.2.3 By Type - Global Naloxegol Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Naloxegol Market Size, 2021 & 2028
  5.1.2 Pharmacy
  5.1.3 Hospital
  5.1.4 Clinic
  5.1.5 Others
5.2 By Application - Global Naloxegol Revenue & Forecasts
  5.2.1 By Application - Global Naloxegol Revenue, 2017-2022
  5.2.2 By Application - Global Naloxegol Revenue, 2023-2028
  5.2.3 By Application - Global Naloxegol Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Naloxegol Market Size, 2021 & 2028
6.2 By Region - Global Naloxegol Revenue & Forecasts
  6.2.1 By Region - Global Naloxegol Revenue, 2017-2022
  6.2.2 By Region - Global Naloxegol Revenue, 2023-2028
  6.2.3 By Region - Global Naloxegol Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Naloxegol Revenue, 2017-2028
  6.3.2 US Naloxegol Market Size, 2017-2028
  6.3.3 Canada Naloxegol Market Size, 2017-2028
  6.3.4 Mexico Naloxegol Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Naloxegol Revenue, 2017-2028
  6.4.2 Germany Naloxegol Market Size, 2017-2028
  6.4.3 France Naloxegol Market Size, 2017-2028
  6.4.4 U.K. Naloxegol Market Size, 2017-2028
  6.4.5 Italy Naloxegol Market Size, 2017-2028
  6.4.6 Russia Naloxegol Market Size, 2017-2028
  6.4.7 Nordic Countries Naloxegol Market Size, 2017-2028
  6.4.8 Benelux Naloxegol Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Naloxegol Revenue, 2017-2028
  6.5.2 China Naloxegol Market Size, 2017-2028
  6.5.3 Japan Naloxegol Market Size, 2017-2028
  6.5.4 South Korea Naloxegol Market Size, 2017-2028
  6.5.5 Southeast Asia Naloxegol Market Size, 2017-2028
  6.5.6 India Naloxegol Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Naloxegol Revenue, 2017-2028
  6.6.2 Brazil Naloxegol Market Size, 2017-2028
  6.6.3 Argentina Naloxegol Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Naloxegol Revenue, 2017-2028
  6.7.2 Turkey Naloxegol Market Size, 2017-2028
  6.7.3 Israel Naloxegol Market Size, 2017-2028
  6.7.4 Saudi Arabia Naloxegol Market Size, 2017-2028
  6.7.5 UAE Naloxegol Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 MOVANTIK
  7.1.1 MOVANTIK Corporate Summary
  7.1.2 MOVANTIK Business Overview
  7.1.3 MOVANTIK Naloxegol Major Product Offerings
  7.1.4 MOVANTIK Naloxegol Revenue in Global Market (2017-2022)
  7.1.5 MOVANTIK Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Naloxegol Major Product Offerings
  7.2.4 AstraZeneca Naloxegol Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Aurobindo
  7.3.1 Aurobindo Corporate Summary
  7.3.2 Aurobindo Business Overview
  7.3.3 Aurobindo Naloxegol Major Product Offerings
  7.3.4 Aurobindo Naloxegol Revenue in Global Market (2017-2022)
  7.3.5 Aurobindo Key News
7.4 MSN Life Sciences
  7.4.1 MSN Life Sciences Corporate Summary
  7.4.2 MSN Life Sciences Business Overview
  7.4.3 MSN Life Sciences Naloxegol Major Product Offerings
  7.4.4 MSN Life Sciences Naloxegol Revenue in Global Market (2017-2022)
  7.4.5 MSN Life Sciences Key News
7.5 Lepu
  7.5.1 Lepu Corporate Summary
  7.5.2 Lepu Business Overview
  7.5.3 Lepu Naloxegol Major Product Offerings
  7.5.4 Lepu Naloxegol Revenue in Global Market (2017-2022)
  7.5.5 Lepu Key News
7.6 Daiichi Sankyo Company
  7.6.1 Daiichi Sankyo Company Corporate Summary
  7.6.2 Daiichi Sankyo Company Business Overview
  7.6.3 Daiichi Sankyo Company Naloxegol Major Product Offerings
  7.6.4 Daiichi Sankyo Company Naloxegol Revenue in Global Market (2017-2022)
  7.6.5 Daiichi Sankyo Company Key News
7.7 Knight Therapeutics
  7.7.1 Knight Therapeutics Corporate Summary
  7.7.2 Knight Therapeutics Business Overview
  7.7.3 Knight Therapeutics Naloxegol Major Product Offerings
  7.7.4 Knight Therapeutics Naloxegol Revenue in Global Market (2017-2022)
  7.7.5 Knight Therapeutics Key News
7.8 Kyowa Kirin International
  7.8.1 Kyowa Kirin International Corporate Summary
  7.8.2 Kyowa Kirin International Business Overview
  7.8.3 Kyowa Kirin International Naloxegol Major Product Offerings
  7.8.4 Kyowa Kirin International Naloxegol Revenue in Global Market (2017-2022)
  7.8.5 Kyowa Kirin International Key News
7.9 Nektar Therapeutics
  7.9.1 Nektar Therapeutics Corporate Summary
  7.9.2 Nektar Therapeutics Business Overview
  7.9.3 Nektar Therapeutics Naloxegol Major Product Offerings
  7.9.4 Nektar Therapeutics Naloxegol Revenue in Global Market (2017-2022)
  7.9.5 Nektar Therapeutics Key News
7.10 RedHill Biopharma Ltd.
  7.10.1 RedHill Biopharma Ltd. Corporate Summary
  7.10.2 RedHill Biopharma Ltd. Business Overview
  7.10.3 RedHill Biopharma Ltd. Naloxegol Major Product Offerings
  7.10.4 RedHill Biopharma Ltd. Naloxegol Revenue in Global Market (2017-2022)
  7.10.5 RedHill Biopharma Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Naloxegol Market Opportunities & Trends in Global Market
Table 2. Naloxegol Market Drivers in Global Market
Table 3. Naloxegol Market Restraints in Global Market
Table 4. Key Players of Naloxegol in Global Market
Table 5. Top Naloxegol Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Naloxegol Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Naloxegol Revenue Share by Companies, 2017-2022
Table 8. Global Companies Naloxegol Product Type
Table 9. List of Global Tier 1 Naloxegol Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Naloxegol Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Naloxegol Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Naloxegol Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Naloxegol Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Naloxegol Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Naloxegol Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Naloxegol Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Naloxegol Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Naloxegol Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Naloxegol Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Naloxegol Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Naloxegol Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Naloxegol Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Naloxegol Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Naloxegol Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Naloxegol Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Naloxegol Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Naloxegol Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Naloxegol Revenue, (US$, Mn), 2023-2028
Table 30. MOVANTIK Corporate Summary
Table 31. MOVANTIK Naloxegol Product Offerings
Table 32. MOVANTIK Naloxegol Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Naloxegol Product Offerings
Table 35. AstraZeneca Naloxegol Revenue (US$, Mn), (2017-2022)
Table 36. Aurobindo Corporate Summary
Table 37. Aurobindo Naloxegol Product Offerings
Table 38. Aurobindo Naloxegol Revenue (US$, Mn), (2017-2022)
Table 39. MSN Life Sciences Corporate Summary
Table 40. MSN Life Sciences Naloxegol Product Offerings
Table 41. MSN Life Sciences Naloxegol Revenue (US$, Mn), (2017-2022)
Table 42. Lepu Corporate Summary
Table 43. Lepu Naloxegol Product Offerings
Table 44. Lepu Naloxegol Revenue (US$, Mn), (2017-2022)
Table 45. Daiichi Sankyo Company Corporate Summary
Table 46. Daiichi Sankyo Company Naloxegol Product Offerings
Table 47. Daiichi Sankyo Company Naloxegol Revenue (US$, Mn), (2017-2022)
Table 48. Knight Therapeutics Corporate Summary
Table 49. Knight Therapeutics Naloxegol Product Offerings
Table 50. Knight Therapeutics Naloxegol Revenue (US$, Mn), (2017-2022)
Table 51. Kyowa Kirin International Corporate Summary
Table 52. Kyowa Kirin International Naloxegol Product Offerings
Table 53. Kyowa Kirin International Naloxegol Revenue (US$, Mn), (2017-2022)
Table 54. Nektar Therapeutics Corporate Summary
Table 55. Nektar Therapeutics Naloxegol Product Offerings
Table 56. Nektar Therapeutics Naloxegol Revenue (US$, Mn), (2017-2022)
Table 57. RedHill Biopharma Ltd. Corporate Summary
Table 58. RedHill Biopharma Ltd. Naloxegol Product Offerings
Table 59. RedHill Biopharma Ltd. Naloxegol Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Naloxegol Segment by Type in 2021
Figure 2. Naloxegol Segment by Application in 2021
Figure 3. Global Naloxegol Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Naloxegol Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Naloxegol Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Naloxegol Revenue in 2021
Figure 8. By Type - Global Naloxegol Revenue Market Share, 2017-2028
Figure 9. By Application - Global Naloxegol Revenue Market Share, 2017-2028
Figure 10. By Region - Global Naloxegol Revenue Market Share, 2017-2028
Figure 11. By Country - North America Naloxegol Revenue Market Share, 2017-2028
Figure 12. US Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Naloxegol Revenue Market Share, 2017-2028
Figure 16. Germany Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 17. France Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Naloxegol Revenue Market Share, 2017-2028
Figure 24. China Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 28. India Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Naloxegol Revenue Market Share, 2017-2028
Figure 30. Brazil Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Naloxegol Revenue Market Share, 2017-2028
Figure 33. Turkey Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Naloxegol Revenue, (US$, Mn), 2017-2028
Figure 37. MOVANTIK Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aurobindo Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. MSN Life Sciences Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lepu Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Daiichi Sankyo Company Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Knight Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kyowa Kirin International Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Nektar Therapeutics Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. RedHill Biopharma Ltd. Naloxegol Revenue Year Over Year Growth (US$, Mn) & (2017-2022)